Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Home - Clinical Trials Arena
WEBAt the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be allowed to advance without political interference. Catherine Longworth. Analyst Comment.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA
WEBJun 19, 2024 · Mounjaro ™ (tirzepatide) is a dual-targeted, injectable, sustained-release therapy indicated for the treatment of type 2 diabetes (T2D) in adults as an adjunct to diet and exercise.. Developed by Eli Lilly, a pharmaceutical company based in the US, Mounjaro is the first and only once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor ...
News - Clinical Trials Arena
WEBIpsen shelves Cabometyx combo in prostate cancer after Phase III miss. One of Ipsen’s flagship oncology assets Cabometyx (cabozantinib) will not be gaining an indication in prostate cancer outside the US…. Robert Barrie. News.
Phase 0 clinical trials: what you need to know
WEBJul 21, 2022 · Clinical Trials Arena breaks down the two most common types of Phase 0 trials, including window of opportunity trials in neuro-oncology. William Newton July 21, 2022. When the FDA introduced Phase 0 trials in 2006, the goal was to learn more about new drugs without exposing subjects to their full, potentially toxic, effects.
EU Clinical Trial Regulation: What You Need to Know
WEBMay 20, 2021 · The way clinical trials are conducted in the EU will undergo a major transformation once the Clinical Trial Regulation comes into effect. The regulation will replace the existing Clinical Trials Directive 2001/20/EC and will harmonise the registration, assessment and supervision processes for clinical trials throughout the EU via the CTIS.
Ozempic (semaglutide) for the Treatment of Type 2 Diabetes
WEBOzempic ® (semaglutide) is a glucagon-like peptide (GLP-1) receptor agonist indicated for the treatment of Type 2 diabetes in adults. The drug was discovered and developed by Novo Nordisk, which submitted a new drug application (NDA) for the drug to the US Food and Drug Administration (FDA) under the Prescription Drug User Fee Act V (PDUFA V ...
Biosimilars: top 10 pharma companies leading the way
WEBJan 20, 2022 · Yesterday (19 January), using the same Thematic Research ecosystem, Clinical Trials Arena revealed the top pharma companies best equipped with artificial intelligence. According to our analysis, Novartis, Pfizer, Catalent, Amgen, Biogen, Patheon, Shanghai Henlius Biotech, Viatris, Celltrion, and Samsung Bioepis are …
Contract Research Organizations for the Clinical Trials Industry
WEBContract research organizations for the clinical trials industry. Contract research organizations (CROs), also known as clinical research organizations, offer their technical expertise and development support across all phases of development to pharmaceutical, biotechnology, and medical device companies on a contractual basis.